79 related articles for article (PubMed ID: 10437983)
1. Immunogenicity of thrombopoietin mimetic peptide GW395058 in BALB/c mice and New Zealand white rabbits: evaluation of the potential for thrombopoietin neutralizing antibody production in man.
de Serres M; Ellis B; Dillberger JE; Rudolph SK; Hutchins JT; Boytos CM; Weigl DL; DePrince RB
Stem Cells; 1999; 17(4):203-9. PubMed ID: 10437983
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and hematological effects of the PEGylated thrombopoietin peptide mimetic GW395058 in rats and monkeys after intravenous or subcutaneous administration.
de Serres M; Yeager RL; Dillberger JE; Lalonde G; Gardner GH; Rubens CA; Simkins AH; Sailstad JM; McNulty MJ; Woolley JL
Stem Cells; 1999; 17(6):316-26. PubMed ID: 10606160
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics and pharmacodynamics of GW395058, a peptide agonist of the thrombopoietin receptor, in the dog, a large-animal model of chemotherapy-induced thrombocytopenia.
Case BC; Hauck ML; Yeager RL; Simkins AH; de Serres M; Schmith VD; Dillberger JE; Page RL
Stem Cells; 2000; 18(5):360-5. PubMed ID: 11007920
[TBL] [Abstract][Full Text] [Related]
4. [Expression of TPO mimetic peptide chimeric proteins with human IgG1 Fc fragments and their biological characters].
Li YX; Li C; Tao KH; Jia XH; Cheng DS; Huang PT
Sheng Wu Gong Cheng Xue Bao; 2002 Jul; 18(4):424-30. PubMed ID: 12385237
[TBL] [Abstract][Full Text] [Related]
5. Thrombopoietin (TPO) knockout phenotype induced by cross-reactive antibodies against TPO following injection of mice with recombinant adenovirus encoding human TPO.
Abina MA; Tulliez M; Duffour MT; Debili N; Lacout C; Villeval JL; Wendling F; Vainchenker W; Haddada H
J Immunol; 1998 May; 160(9):4481-9. PubMed ID: 9574554
[TBL] [Abstract][Full Text] [Related]
6. Determination of thrombopoietin-derived peptides recognized by both cellular and humoral immunities in healthy donors and patients with thrombocytopenia.
Takedatsu H; Yoshimoto K; Okamura T; Miyazaki H; Kuwaki T; Sata M; Itoh K
Stem Cells; 2005 Aug; 23(7):975-82. PubMed ID: 16043461
[TBL] [Abstract][Full Text] [Related]
7. Neutralization of biological activity and inhibition of receptor binding by antibodies against human thrombopoietin.
Tahara T; Kuwaki T; Matsumoto A; Morita H; Watarai H; Inagaki Y; Ohashi H; Ogami K; Miyazaki H; Kato T
Stem Cells; 1998; 16(1):54-60. PubMed ID: 9474748
[TBL] [Abstract][Full Text] [Related]
8. Physiologic role of TPO in thrombopoiesis.
Miyazaki H
Stem Cells; 1996; 14 Suppl 1():133-8. PubMed ID: 11012213
[TBL] [Abstract][Full Text] [Related]
9. [Adenovirus long-term expression of thrombopoietin in vivo: a new model for myeloproliferative syndrome and osteomyelofibrosis].
Frey BM; Rafii S; Crystal RG; Moore MA
Schweiz Med Wochenschr; 1998 Oct; 128(42):1587-92. PubMed ID: 9824887
[TBL] [Abstract][Full Text] [Related]
10. Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.
Newland A
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S35-45. PubMed ID: 18096471
[TBL] [Abstract][Full Text] [Related]
11. A rationally designed agonist antibody fragment that functionally mimics thrombopoietin.
Frederickson S; Renshaw MW; Lin B; Smith LM; Calveley P; Springhorn JP; Johnson K; Wang Y; Su X; Shen Y; Bowdish KS
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14307-12. PubMed ID: 16973749
[TBL] [Abstract][Full Text] [Related]
12. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity.
Olszewska W; Obeid OE; Steward MW
Virology; 2000 Jun; 272(1):98-105. PubMed ID: 10873752
[TBL] [Abstract][Full Text] [Related]
13. Sensitive measurement of thrombopoietin by a monoclonal antibody based sandwich enzyme-linked immunosorbent assay.
Folman CC; von dem Borne AE; Rensink IH; Gerritsen W; van der Schoot CE; de Haas M; Aarden L
Thromb Haemost; 1997 Oct; 78(4):1262-7. PubMed ID: 9364995
[TBL] [Abstract][Full Text] [Related]
14. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis.
Nogami W; Yoshida H; Koizumi K; Yamada H; Abe K; Arimura A; Yamane N; Takahashi K; Yamane A; Oda A; Tanaka Y; Takemoto H; Ohnishi Y; Ikeda Y; Miyakawa Y
Haematologica; 2008 Oct; 93(10):1495-504. PubMed ID: 18728031
[TBL] [Abstract][Full Text] [Related]
15. The CBD1 peptide corresponding to the caveolin-1 binding domain of HIV-1 glycoprotein gp41 elicits neutralizing antibodies in cynomolgus macaques when administered with the tetanus T helper epitope.
Benferhat R; Martinon F; Krust B; Le Grand R; Hovanessian AG
Mol Immunol; 2009 Feb; 46(4):705-12. PubMed ID: 19010547
[TBL] [Abstract][Full Text] [Related]
16. Peptide agonists of the thrombopoietin receptor.
Dower WJ; Cwirla SE; Balasubramanian P; Schatz PJ; Baccanari DP; Barrett RW
Stem Cells; 1998; 16 Suppl 2():21-9. PubMed ID: 11012174
[TBL] [Abstract][Full Text] [Related]
17. The immunogenicity of a conformationally restricted peptide mimetic of meningococcal lipooligosaccharide.
Tiwana H; Clow KJ; Hall C; Feavers IM; Charalambous BM
Scand J Immunol; 2005 Oct; 62(4):385-92. PubMed ID: 16253126
[TBL] [Abstract][Full Text] [Related]
18. Impact of chicken thrombopoietin and its receptor c-Mpl on hematopoietic cell development.
Bartunek P; Karafiat V; Bartunkova J; Pajer P; Dvorakova M; Kralova J; Zenke M; Dvorak M
Exp Hematol; 2008 Apr; 36(4):495-505. PubMed ID: 18243490
[TBL] [Abstract][Full Text] [Related]
19. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
[TBL] [Abstract][Full Text] [Related]
20. Recombinant viral-like particles of parvovirus B19 as antigen carriers of anthrax protective antigen.
Ogasawara Y; Amexis G; Yamaguchi H; Kajigaya S; Leppla SH; Young NS
In Vivo; 2006; 20(3):319-24. PubMed ID: 16724664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
